Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Revenues [Abstract]
Revenue	$ 6,000	$ 3,000	$ 25,000	$ 9,000
Operating Expenses
Research and development	22,500	114,620	79,939	184,301
General and administrative	82,927	49,938	190,154	159,326
Total Operating Expenses	105,427	164,558	270,093	343,627
Loss from Operations	(99,427)	(161,558)	(245,093)	(334,627)
Other Income (Expenses)
Loss on impairment	0	0	0	(69,178)
Interest expense	(23,124)	(9,265)	(48,273)	(23,009)
Total Other Expenses	(23,124)	(9,265)	(48,273)	(92,187)
Loss before Income Taxes	(23,124)	(9,265)	(293,366)	(92,187)
Provision for Income Taxes	0	0	0	0
Net Loss	$ (122,551)	$ (170,823)	$ (293,366)	$ (426,814)
Net Loss per Share - Basic and Diluted	$ (0.00)	$ (0.00)	$ (0.01)	$ (0.01)
Weighted Average Common Shares Outstanding - Basic and Diluted	31,706,602	31,750,106	31,735,499	31,750,106